Rights and permissions
About this article
Cite this article
Basiliximab: economic advantage for renal transplantation in Japan. Pharmacoecon. Outcomes News 405, 9 (2003). https://doi.org/10.1007/BF03276037
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276037